LLY - Eli Lilly and Company

Profile for Eli Lilly and Company (LLY)

After Hours: $ 30.43

0.00 (0.00%)

Volume: 273.81 k

7:22 PM EST Nov 21, 2008

Business Description:
The Company discovers, develops, manufactures and sells products in one segment of pharmaceutical products.

Address:

Lilly Corporate Center, Indianapolis, IN 46285

Telephone:

(317) 276-2000

Website:

www.lilly.com

Facsimile:

(317) 276-4878

Email:

Details

CEO:

Dr. John C. Lechleiter, Ph.D.

Employees:

40600

Market Cap:

34.6 b

Issue Type:

Common Stock

Auditor:

Ernst & Young LLP

Last Audit:

Unqualified

Indices:

DJ US Pharmaceuticals, Fortune 500 Industrial, Drug Manufacturers - Major, Russell 1000, S&P 1500 Pharmaceuticals Index, S&P 500 Pharmaceuticals Index, S&P 900 Pharmaceuticals Index, S&P Composite

Industry Classifications

Sector:

Healthcare

CIK:

0000059478

Industry:

Drugs

NAICS:

Pharmaceutical Preparation Manufacturing (325412)

QM ID:

Drug Manufacturers - Major (510)

SIC:

Pharmaceutical Preparations (2834)

Profitability

Management Effectiveness

Gross Margin:

82.20

Return on Equity:

17.60

EBIT Margin:

16.20

Return on Capital:

13.50

Profit Margin:

15.10

Return on Assets:

8.70

Share Statistics

Outstanding:

1.14 b

Float:

1.13 b

Short Interest:

10.38 m (as of 10/28/08)

Short Int Ratio:

1.20

% of Float:

0.90%

Non-Corp. Insider Hold'gs:

0.20% (as of 9/1/08)

Bought Prev 3 Mo:

328

Sold Prev 3 Mo:

1.82 m

Institution Hold'gs:

78.30% (as of 10/1/08)

Total Held:

889.71 m

Institutions:

1082

Bought Prev Mo:

38.21 m

Sold Prev Mo:

42.31 m